IM Cannabis Corp (NAS:IMCC)
$ 0.14 -0.017 (-10.7%) Market Cap: 1.27 Mil Enterprise Value: 11.04 Mil PE Ratio: 0 PB Ratio: 0 GF Score: 36/100

Q4 2024 IM Cannabis Corp Earnings Call Transcript

Mar 31, 2025 / 01:00 PM GMT
Release Date Price: $1.51 (-17.87%)

Key Points

Positve
  • IM Cannabis Corp (IMCC) experienced extraordinary growth in the German market following partial legalization in April 2024.
  • The company reduced operating expenses by 53% since 2022, with a significant impact in Q4 2024.
  • IM Cannabis Corp (IMCC) achieved a positive adjusted EBITDA of $0.5 million in Q4 2024, compared to a loss of $4.3 million in Q4 2023.
  • Sales in Germany increased by 280% in Q4 2024 compared to Q4 2023, contributing significantly to overall revenue growth.
  • The company successfully integrated its supply chain and launched 16 new strains in 2024, supporting future growth.
Negative
  • IM Cannabis Corp (IMCC) faced a net loss of $11.8 million for 2024, an increase from $10.2 million in 2023.
  • The Israeli market saw a revenue decline due to the cancellation of a significant agreement, impacting overall performance.
  • Gross profit decreased by 14% in 2024 compared to 2023, affected by inventory write-offs and increased material costs.
  • The company anticipates ongoing price compression in the competitive German market, which may impact future margins.
  • Cash and cash equivalents decreased to $0.9 million as of December 31, 2024, from $1.8 million the previous year, indicating potential liquidity concerns.


Refinitiv StreetEvents Event Transcript
E D I T E D V E R S I O N

IMCC.CD - IM Cannabis Corp
Q4 2024 IM Cannabis Corp Earnings Call
Mar 31, 2025 / 01:00PM GMT

=====================
Presentation
--------------------------------------------------------------------------------
Unidentified_1 [1]
--------------------------------------------------------------------------------
Good morning and welcome to I Am Cannabis's 4th quarter and full year 2024 earnings conference call.

Today's conference call is being recorded. At this time, I would like to turn the conference over to Ana Tarano, director of Investor and Public relations. Anna.

--------------------------------------------------------------------------------
Unidentified_2 [2]
--------------------------------------------------------------------------------
Good morning and thank you, operator. Joining me for today's call are I am Cannabis, Chief Executive Officer Oren Schuster and Chief Financial Officer, Uri Brenberg. The earnings and press release that accompanies this call is available on the investor relations section of
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot